Skip to main content
. 2022 Dec 19;25(1):56–67. doi: 10.1038/s41556-022-01035-2

Extended Data Fig. 9. Hexanediol and nocodazole treatment.

Extended Data Fig. 9

a, Micrographs of mNeonGreen-Bim1 and mNeonGreen-Bik1 expressing control and 5% hexanediol treated cells as quantified in Fig. 7e. Since these cells did not express CFP-Tub1, the transmission channel is used as a reference in magenta. Scale bar, 3 μm. b, Micrographs of GFP-Tub1 expressing control, 5% hexanediol, and 30 μg/mL nocodazole treated cells. c, Frequency of cells with visible astral microtubules labeled with GFP-Tub1 in control, 5% hexanediol, and 30 μg/mL nocodazole treatment (error bars are Wilson/Brown 95% confidence intervals determined from binomial distribution). P values above bars are determined by two-proportion z test. d, Micrographs of cells expressing Kar9-mNeonGreen treated with 30 μg/mL nocodazole versus control. e, Kar9-mNeonGreen fluorescence intensity levels in wild-type cells treated with 5% hexanediol or 30 μg/mL nocodazole versus untreated control (normalized median with 95% confidence intervals, the control and 5% hexanediol data are the same as shown in Fig. 7e). P values were determined by Welch’s t-test. Blue values in panels c,e indicate n = number of cells analyzed, single experiment. Related to Fig. 7d,e. Source numerical data available in source data.

Source data